Quick answer
Tesamorelin therapy reduces excess abdominal fat and improves body composition by naturally stimulating growth hormone production.
Options
Pick what fits
Benefits
What to expect
- Significant visceral fat reduction, especially in the abdominal area, while preserving lean muscle mass.
- Increased skeletal muscle area and density, particularly in truncal and abdominal muscle groups.
- Reduced cardiovascular disease risk and improved lipid profiles due to visceral fat loss.
Ideal for
Who this helps
Individuals with HIV-associated lipodystrophyPatients with central obesity and elevated cardiovascular riskAdults seeking body composition improvementsIndividuals with documented growth hormone deficiency
How it works
The procedure
01
Tesamorelin, a GHRH analog, binds to GHRH receptors on pituitary somatotroph cells.
02
This binding stimulates the natural pulsatile release of endogenous growth hormone (GH) from the pituitary gland.
03
GH then acts on various tissues, promoting lipolysis in visceral adipose tissue and enhancing protein synthesis in muscle.
04
The sustained elevation of natural GH levels leads to a significant and targeted reduction of visceral fat and improvements in lean muscle mass.
Conditions
Treats
FAQ
Frequently asked
More services
